Our results demonstrated a marked decrease in the mRNA expression of SDC2 (P < 0.01) and FN (P < 0.05) in tumor tissue samples from pLNM breast cancer patients compared to those with nLNM (Fig. 4A&B). The gene discussed is SDC2; the disease is breast cancer.